Alyeska Investment Group’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-50,000
Closed -$598K 645
2024
Q2
$598K Buy
+50,000
New +$596K ﹤0.01% 493
2024
Q1
Sell
-50,000
Closed -$562K 569
2023
Q4
$562K Buy
+50,000
New +$519K ﹤0.01% 430
2023
Q3
Sell
-50,000
Closed -$617K 590
2023
Q2
$617K Buy
+50,000
New +$557K ﹤0.01% 482

Other funds holding OCS

Alyeska Investment Group's OCS Position: Q1 2026 in Review

Alyeska Investment Group held its Oculis Holding (OCS) position steady in Q1 2026 at 331,332 shares worth $8.81M. The position accounts for 0.02% of the portfolio, ranked #416.

Alyeska Investment Group first reported a position in OCS in Q1 2025 and has held it in 5 quarters since. 57 funds tracked by Wall St. Rank hold OCS as of Q1 2026.

  • Alyeska Investment Group held 331,332 shares of Oculis Holding worth $8.81M as of Q1 2026.
  • Alyeska Investment Group left its Oculis Holding share count unchanged in Q1 2026.
  • Oculis Holding made up 0.02% of Alyeska Investment Group's portfolio in Q1 2026, its #416 holding.
  • Alyeska Investment Group first reported a position in Oculis Holding in Q1 2025 and has held it in 5 quarters since.
  • 57 funds tracked by Wall St. Rank held Oculis Holding as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.